Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Postbariatric Hypoglycemia ...

Hypoglycemia is the major barrier to good glycemic control in patients with diabetes mellitus. Furthermore, randomized controlled trials have emphasized the grave risks associated with severe ...

NNC2215, a glucose-sensitive insulin, offers improved glycemic control by dynamically adjusting to blood sugar levels, ...

Glycemic and hypoglycemia treatment targets should be individualized and reassessed every 3–6 months. If targets are not met, one diabetes technology—continuous subcutaneous insulin infusion ...

While insulin treatment in diabetic patients is extremely effective in lowering blood glucose from dangerous highs, the authors continued, episodes of moderate to severe hypoglycemia are common ...

An insulin that switches itself on and off in response to blood glucose levels has proven successful in lowering the risk of ...

The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...

and transplant interventions in patients with T1D complicated by problematic hypoglycemia (Table 2) and to propose clinical practice recommendations (Table 3) in a tiered, four-stage treatment ...

However, if glucose levels plunge too low—from taking too much insulin or not eating enough sugar—people can experience ...

Though most people with type 1 diabetes occasionally experience hypoglycemia, it’s usually not dangerous and can be easily treated with high-carb foods, beverages, or glucose tabs. However, if left ...